These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26519437)

  • 1. Hippocampal Lipid Homeostasis in APP/PS1 Mice is Modulated by a Complex Interplay Between Dietary DHA and Estrogens: Relevance for Alzheimer's Disease.
    Díaz M; Fabelo N; Casañas-Sánchez V; Marin R; Gómez T; Quinto-Alemany D; Pérez JA
    J Alzheimers Dis; 2016; 49(2):459-81. PubMed ID: 26519437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifactor Analyses of Frontal Cortex Lipids in the APP/PS1 Model of Familial Alzheimer's Disease Reveal Anomalies in Responses to Dietary n-3 PUFA and Estrogenic Treatments.
    Díaz M
    Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
    Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
    Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
    Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
    Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the effects of phosphatidylcholine rich in DHA and EPA on Alzheimer's disease and the possible mechanisms in CHO-APP/PS1 cells and SAMP8 mice.
    Che H; Zhou M; Zhang T; Zhang L; Ding L; Yanagita T; Xu J; Xue C; Wang Y
    Food Funct; 2018 Jan; 9(1):643-654. PubMed ID: 29292421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models.
    Zhang B; Tang XC; Zhang HY
    J Neurosci Res; 2013 May; 91(5):717-25. PubMed ID: 23401344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice.
    Oksman M; Iivonen H; Hogyes E; Amtul Z; Penke B; Leenders I; Broersen L; Lütjohann D; Hartmann T; Tanila H
    Neurobiol Dis; 2006 Sep; 23(3):563-72. PubMed ID: 16765602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
    Hooijmans CR; Rutters F; Dederen PJ; Gambarota G; Veltien A; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Tanila H; Kiliaan AJ
    Neurobiol Dis; 2007 Oct; 28(1):16-29. PubMed ID: 17720508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for premature lipid raft aging in APP/PS1 double-transgenic mice, a model of familial Alzheimer disease.
    Fabelo N; Martín V; Marín R; Santpere G; Aso E; Ferrer I; Díaz M
    J Neuropathol Exp Neurol; 2012 Oct; 71(10):868-81. PubMed ID: 22975585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AβPPswe/PS1dE9 mice.
    Broersen LM; Kuipers AA; Balvers M; van Wijk N; Savelkoul PJ; de Wilde MC; van der Beek EM; Sijben JW; Hageman RJ; Kamphuis PJ; Kiliaan AJ
    J Alzheimers Dis; 2013; 33(1):177-90. PubMed ID: 22914588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention.
    Ma QL; Teter B; Ubeda OJ; Morihara T; Dhoot D; Nyby MD; Tuck ML; Frautschy SA; Cole GM
    J Neurosci; 2007 Dec; 27(52):14299-307. PubMed ID: 18160637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice.
    Hooijmans CR; Van der Zee CE; Dederen PJ; Brouwer KM; Reijmer YD; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Kiliaan AJ
    Neurobiol Dis; 2009 Mar; 33(3):482-98. PubMed ID: 19130883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
    Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Astaxanthin and Docosahexaenoic-Acid-Acylated Astaxanthin on Alzheimer's Disease in APP/PS1 Double-Transgenic Mice.
    Che H; Li Q; Zhang T; Wang D; Yang L; Xu J; Yanagita T; Xue C; Chang Y; Wang Y
    J Agric Food Chem; 2018 May; 66(19):4948-4957. PubMed ID: 29695154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
    Zhao G; Liu HL; Zhang H; Tong XJ
    Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice.
    Zhang J; Guo J; Zhao X; Chen Z; Wang G; Liu A; Wang Q; Zhou W; Xu Y; Wang C
    Behav Brain Res; 2013 Aug; 250():230-7. PubMed ID: 23685322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Pedrós I; Petrov D; Allgaier M; Sureda F; Barroso E; Beas-Zarate C; Auladell C; Pallàs M; Vázquez-Carrera M; Casadesús G; Folch J; Camins A
    Biochim Biophys Acta; 2014 Sep; 1842(9):1556-66. PubMed ID: 24887203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.